Peptide Synthesis Market To Reach USD 973.2 million by 2028 with a CAGR of 6.7%| Valuates Reports

News provided by

17 Feb, 2023, 15:05 GMT

BANGALORE, India, Feb. 17, 2023 /PRNewswire/ -- Peptide Synthesis Market is segmented by type (CRO Peptides, CMO Peptides, Generic API Peptides), By application (Commercial, Academic Research) : Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.

Due to the COVID-19 pandemic, the global Peptide Synthesis market size is estimated to be worth USD 659.5 million in 2022 and is forecast to a readjusted size of USD 973.2 million by 2028 with a CAGR of 6.7% during the review period.

Major factors driving the growth of the Peptide Synthesis Market

Peptide therapies provide a number of advantages over other treatment classes, including good selectivity, stability, efficacy, safety, bioavailability, and tolerance. These advantages are expected to fuel the Peptide Therapeutics market.

The acceptance of peptide treatments will be influenced by the rise in metabolic diseases like osteoporosis, obesity, and diabetes as well as the incidence of cancer. There is a huge demand for effective and affordable medications because of the sheer increase in the number of pediatric patients affected and the prevalence of the target diseases in low-income nations.

The increase in product development and technological advancements is another prominent market trend that is projected to boost the Peptide Therapeutics market.

Get a Free Sample:

https://reports.valuates.com/request/sample/QYRE-Auto-6143/Global_Peptide_Synthesis_Market

TRENDS INFLUENCING THE GROWTH OF THE PEPTIDE SYNTHESIS MARKET

For newly developed anti-cancer drugs, the field of peptide therapies appears promising. Benefits include simplicity, speed, and the ability to modify peptide production. The two leading causes of death in industrialized nations are cancer and cardiovascular disease. Therapeutic peptides are a novel and potentially effective treatment for a variety of disorders, including cancer. They are superior to proteins and antibodies in a number of ways, including ease of synthesis, high target specificity and selectivity, and minimal toxicity. Chemotherapy based on peptides has been one of these novel techniques that have attracted a lot of attention because of the special benefits of peptides, such as their low molecular weight, capacity to target just tumor cells, and low toxicity in healthy tissues. This factor is expected to drive the growth of the Peptide Therapeutics market.

The emergence of peptide-based therapeutics has brought metabolic illnesses a great deal of attention. It is important to note that numerous unique technologies created by medication and technology developers have helped peptides develop into effective therapeutic treatments. Technologies created to improve peptide stability, and bioavailability, and promote effective distribution have played a significant role in the market's expansion. Particularly, it is anticipated that patient compliance would be greatly enhanced by technologies that allow sustained drug delivery over a longer time period and different routes of administration (oral, intranasal, and transdermal). In order to either acquire or create peptide medicines, firms have actively engaged in collaboration with various stakeholders. This factor is expected to drive the growth of the Peptide Therapeutics market.

Peptides are known for being extremely effective and selective while also being generally safe and well-tolerated. As a result, peptides are receiving more attention in pharmaceutical research and development (R&D). Peptides have been widely used in biotechnology and medicine over the past ten years, and therapeutic peptide research is currently enjoying a revival for financial reasons. This is expected to further fuel the Peptide Therapeutics market.

Peptides are also considerably smaller than proteins (when compared to proteins) and are simple to produce, improve, and test as potential therapeutic treatments for a variety of illnesses. The last ten years have seen a clear movement in the focus of pharmaceutical and life science businesses towards the development of peptide-based therapies due to these very advantageous and inherent properties of peptides. Recently, more of these compounds have received marketing clearance.

View Full Report:

https://reports.valuates.com/market-reports/QYRE-Auto-6143/global-peptide-synthesis

PEPTIDE SYNTHESIS SHARE ANALYSIS

The biggest market is North America, which has a share of approximately 55%, followed by Europe and Asia-Pacific, which each have a share of about 40%. The expansion of the biotechnology sector, rising demand for cancer and other disease diagnostics, and increased consumer awareness of peptide therapy products are major drivers of regional market growth.

With a market share of almost 70%, injection is the most significant product segment.

Buy Regional Market Report : https://reports.valuates.com/request/regional/QYRE-Auto-6143/Global_Peptide_Synthesis_Market

Key Companies:

Bachem
PolyPeptide
USV Peptides
Thermofischer
GL Biochem
Hybio
Bio Basic
JPT
Genscript
Xinbang
ScinoPharm
21st Century Bio
CPC Scientific
LifeTein
AnaSpec
New England Peptide
Biomatik
Proimmune

Buy Now for Single User + Covid-19 Impact :

https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-6143&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS:

- Peptide-based Drug market size is estimated to be worth USD 34550 million in 2022 and is forecast to a readjusted size of USD 58070 million by 2028 with a CAGR of 9.0% during the review period.

- Peptide Based Infection Therapeutics market size is projected to reach USD 34800 million by 2028, from USD 23470 million in 2021, at a CAGR of 5.3% during 2022-2028.

- Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market size is projected to reach USD 24210 million by 2028, from USD 17840 million in 2021, at a CAGR of 4.4% during 2022-2028.

- Autoimmune Disease Therapeutics market size is projected to reach USD 119350 million by 2028, from USD 98160 million in 2021, at a CAGR of 2.4% during 2022-2028.

- Nucleic Acid-based Therapeutics market was valued at USD 560.8 million in 2022 and is anticipated to reach USD 705.5 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029.

- Lung Cancer Therapeutics market size is projected to reach USD 46170 million by 2028, from USD 23060 million in 2021, at a CAGR of 10.2% during 2022-2028.

- Psoriatic Arthritis Therapeutics Market estimated at USD 7019.3 million in the year 2022, is projected to reach a revised size of USD 11750 million by 2028, growing at a CAGR of 9.0% during the forecast period 2022-2028.

- Microbiome Therapeutics market size is estimated to be worth USD 91 million in 2022 and is forecast to a readjusted size of USD 892.2 million by 2029 with a CAGR of 38.1% during the forecast period 2023-2029.

- Oligonucleotide Therapeutics market size is estimated to be worth USD 3678.1 million in 2021 and is forecast to a readjusted size of USD 3678.1 million by 2028 with a CAGR of 16.7% during the review period.

- The global single cell analysis market size was valued at USD 2.64 billion in 2021, and is projected to reach USD 13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.

- Stem Cell Banking market size is estimated to be worth USD 1789 million in 2021 and is forecast to a readjusted size of USD 2927.2 million by 2028 with a CAGR of 7.2% during the review period.

- The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

- The global In-vitro Toxicology Testing market size is projected to reach USD 16460 million by 2028, from USD 10560 million in 2021, at a CAGR of 6.5% during 2022-2028.

- Biological Safety Cabinet market size is estimated to be worth USD 213.6 million in 2022 and is forecast to a readjusted size of USD 331.4 million by 2028 with a CAGR of 7.6% during the review period.

- Vein Finder market size is estimated to be worth USD 170.5 million in 2022 and is forecast to a readjusted size of USD 529.8 million by 2028 with a CAGR of 20.8% during the review period.

- Transdermal Patch market size is estimated to be worth USD 7058.3 million in 2022 and is forecast to a readjusted size of USD 8726.9 million by 2028 with a CAGR of 3.6% during the review period.

- The cleanroom consumables market was valued at USD 3688.38 million in 2020, and it is anticipated to reach USD 6658.35 million by 2030, registering a CAGR of about 5.40% during the forecast period (2021 to 2030).

- Global Anticoagulant Drugs Sales Market Report 2022

- Global Pruritus Therapeutics Sales Market Rep ort 2022

Click here to see related reports on Peptide Synthesis Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports

sales@valuates.com

For U.S. Toll-Free Call 1-(315)-215-3225

For IST Call +91-8040957137

WhatsApp: +91-9945648335

Website: https://reports.valuates.com

Twitter - https://twitter.com/valuatesreports

LinkedIn - https://in.linkedin.com/company/valuatesreports

Sitemap: https://reports.valuates.com/sitemap/html/reports/236

https://reports.valuates.com/sitemap/html/reports/237

https://reports.valuates.com/sitemap/html/reports/238